Clinical Rheumatology

, Volume 36, Issue 1, pp 155–163 | Cite as

Depressive symptoms and structural disease progression in knee osteoarthritis: data from the Osteoarthritis Initiative

  • Alan M. Rathbun
  • Michelle S. Yau
  • Michelle Shardell
  • Elizabeth A. Stuart
  • Marc C. Hochberg
Original Article

Abstract

Depressive symptoms are associated with increases in pain and functional limitations in knee osteoarthritis (OA). The aim was to determine whether depressive symptoms are also associated with greater structural knee OA progression. Four years of annual radiographic and clinical assessments from the Osteoarthritis Initiative were analyzed. The Center for Epidemiological Studies Depression Scale was used to identify depressive symptoms (threshold = ≥16) at the baseline visit. Propensity scores were used to match participants with and without baseline depressive symptoms on multiple potential confounders. Assessment of radiographic knee OA was based on changes in individual radiographic features, which included osteophyte (OST) grade and joint space narrowing (JSN) grade. Mixed effect models were used to examine structural progression between depressed and non-depressed participants with definitive radiographic knee OA. Depressive symptoms were significantly associated with a higher risk of OST progression (odds ratio [OR] = 1.74; 95% confidence interval [CI]: 1.01, 3.00) and a non-significant lower risk of JSN progression (OR = 0.40; 95% CI: 0.14, 1.15) 1 year after baseline. Conversely, there was a non-significant lower risk of OST progression (OR = 0.71; 95% CI: 0.28, 1.79) and higher risk of JSN progression (OR = 1.89; 95% CI: 0.71, 5.06) from year 3 to year 4 of follow-up. However, the patterns of OST progression and JSN progression were not significantly different between the depressed and non-depressed (P = 0.25 and 0.15, respectively). The findings provide no evidence that depressive symptoms have a detectable effect on changes in radiographic disease severity in knee OA.

Keywords

Bone Cartilage Epidemiology Osteoarthritis 

Notes

Acknowledgements

The OAI is a public-private partnership composed of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation, GlaxoSmithKline; and Pfizer, Inc. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners.

Compliance with ethical standards

Disclosures

None.

Funding

This research was supported by a training grant (T32 AG000262) from the National Institute on Aging.

Supplementary material

10067_2016_3495_MOESM1_ESM.docx (53 kb)
ESM 1 (DOCX 52 kb)

References

  1. 1.
    Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum 58(1):26–35CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Stubbs B, Aluko Y, Myint PK, Smith TO (2016) Prevalence of depressive symptoms and anxiety in osteoarthritis: a systematic review and meta-analysis. Age Ageing 45(2):228–235CrossRefPubMedGoogle Scholar
  3. 3.
    Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289(23):3095–3105CrossRefPubMedGoogle Scholar
  4. 4.
    Rosemann T, Gensichen J, Sauer N, Laux G, Szecsenyi J (2007) The impact of concomitant depression on quality of life and health service utilisation in patients with osteoarthritis. Rheumatol Int 27(9):859–863CrossRefPubMedGoogle Scholar
  5. 5.
    Lee TA, Shields AE, Vogeli C, Gibson TB, Woong-Sohn M, Marder WD et al (2007) Mortality rate in veterans with multiple chronic conditions. J Gen Intern Med 22(3):403–407CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    CG177 N 2014. Osteoarthritis Care and Management in Adults. London: National Institute for Health and Care ExcellenceGoogle Scholar
  7. 7.
    Detweiler-Bedell JB, Friedman MA, Leventhal H, Miller IW, Leventhal EA (2008) Integrating co-morbid depression and chronic physical disease management: identifying and resolving failures in self-regulation. Clin Psychol Rev 28(8):1426–1446CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Rathbun AM, Harrold LR, Reed GW (2014) A description of patient- and rheumatologist-reported depression symptoms in an American rheumatoid arthritis registry population. Clin Exp Rheumatol 32(4):523–532PubMedGoogle Scholar
  9. 9.
    Lane N, Brandt K, Hawker G, Peeva E, Schreyer E, Tsuji W et al (2011) OARSI-FDA initiative: defining the disease state of osteoarthritis. Osteoarthr Cartil 19(5):478–482CrossRefPubMedGoogle Scholar
  10. 10.
    Bedson J, Croft PR (2008) The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature. BMC Musculoskelet Disord 9:116CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Cohen E, Lee YC (2015) A mechanism-based approach to the management of osteoarthritis pain. Curr Osteoporos Reports 13(6):399–406CrossRefGoogle Scholar
  12. 12.
    Zautra AJ, Smith BW (2001) Depression and reactivity to stress in older women with rheumatoid arthritis and osteoarthritis. Psychosom Med 63(4):687–696CrossRefPubMedGoogle Scholar
  13. 13.
    Dunlop DD, Semanik P, Song J, Manheim LM, Shih V, Chang RW (2005) Risk factors for functional decline in older adults with arthritis. Arthritis Rheum 52(4):1274–1282CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Kroenke K, Wu J, Bair MJ, Krebs EE, Damush TM, Tu W (2011) Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain 12(9):964–973CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Riddle DL, Kong X, Fitzgerald GK (2011) Psychological health impact on 2-year changes in pain and function in persons with knee pain: data from the osteoarthritis initiative. Osteoarthr Cartil 19(9):1095–1101CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Collins J, Katz J, Dervan E, Losina E (2014) Trajectories and risk profiles of pain in persons with radiographic, symptomatic knee osteoarthritis: data from the osteoarthritis initiative. Osteoarthr Cartil 22(5):622–630CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Rathbun AM, Reed GW, Harrold LR (2013) The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review. Rheumatology (Oxford) 52(10):1785–1794CrossRefGoogle Scholar
  18. 18.
    Rohleder N (2014) Stimulation of systemic low-grade inflammation by psychosocial stress. Psychosom Med 76(3):181–189CrossRefPubMedGoogle Scholar
  19. 19.
    Rahmati M, Mobasheri A, Mozafari M (2016) Inflammatory mediators in osteoarthritis: a critical review of the state-of-the-art, current prospects, and future challenges. Bone 85:81–90CrossRefPubMedGoogle Scholar
  20. 20.
    Demakakos P, Cooper R, Hamer M, de Oliveira C, Hardy R, Breeze E (2013) The bidirectional association between depressive symptoms and gait speed: evidence from the English longitudinal study of ageing (ELSA). PLoS One 8(7):e68632CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Beckwee D, Vaes P, Shahabpour M, Muyldermans R, Rommers N, Bautmans I (2015) The influence of joint loading on bone marrow lesions in the knee: a systematic review with meta-analysis. Am J Sports Med 43(12):3093–3107CrossRefPubMedGoogle Scholar
  22. 22.
    Nevitt M, Felson D, Lester G (2006) The osteoarthritis initiative. University of California, San FranciscoGoogle Scholar
  23. 23.
    Radloff LS (1977) The CES-D scale a self-report depression scale for research in the general population. Appl Psychol Meas 1(3):385–401CrossRefGoogle Scholar
  24. 24.
    Zauszniewski JA, Bekhet AK (2009) Depressive symptoms in elderly women with chronic conditions: measurement issues. Aging Mental Health 13(1):64–72CrossRefPubMedGoogle Scholar
  25. 25.
    Smarr KL, Keefer AL (2011) Measures of depression and depressive symptoms: Beck depression inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), geriatric depression scale (GDS), hospital anxiety and depression scale (HADS), and patient health questionnaire-9 (PHQ-9). Arthritis Care Res 63(S11):S454–S466CrossRefGoogle Scholar
  26. 26.
    Altman RD, Gold G (2007) Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthr Cartil 15:A1–A56CrossRefPubMedGoogle Scholar
  27. 27.
    Washburn RA, Smith KW, Jette AM, Janney CA (1993) The physical activity scale for the elderly (PASE): development and evaluation. J Clin Epidemiol 46(2):153–162CrossRefPubMedGoogle Scholar
  28. 28.
    Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47(11):1245–1251CrossRefPubMedGoogle Scholar
  29. 29.
    Bellamy N (1988) Validation study of WOMAC: a health status instrument for measuring clinically-important patient-relevant outcomes following total hip or knee arthroplasty in osteoarthritis. J Orthop Rheumatol 1:95–108Google Scholar
  30. 30.
    KELLGREN JH, LAWRENCE JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16(4):494–502CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Felson DT, Gale DR, Elon Gale M, Niu J, Hunter DJ, Goggins J et al (2005) Osteophytes and progression of knee osteoarthritis. Rheumatology (Oxford) 44(1):100–104CrossRefGoogle Scholar
  32. 32.
    Riddle DL, Kong X, Jiranek WA (2012) Factors associated with rapid progression to knee arthroplasty: complete analysis of three-year data from the osteoarthritis initiative. Joint Bone Spine 79(3):298–303CrossRefPubMedGoogle Scholar
  33. 33.
    Wolfe F, Lane NE (2002) The longterm outcome of osteoarthritis: rates and predictors of joint space narrowing in symptomatic patients with knee osteoarthritis. J Rheumatol 29(1):139–146PubMedGoogle Scholar
  34. 34.
    Karsdal M, Bihlet A, Byrjalsen I, Alexandersen P, Ladel C, Michaels M et al (2015) OA phenotypes, rather than disease stage, drive structural progression–identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA. Osteoarthr Cartil 23(4):550–558CrossRefPubMedGoogle Scholar
  35. 35.
    Hawker GA, Gignac MA, Badley E, Davis AM, French MR, Li Y et al (2011) A longitudinal study to explain the pain-depression link in older adults with osteoarthritis. Arthritis Care Res 63(10):1382–1390CrossRefGoogle Scholar
  36. 36.
    Van der Esch M, Knoop J, van der Leeden M, Roorda L, Lems W, Knol D et al (2015) Clinical phenotypes in patients with knee osteoarthritis: a study in the Amsterdam osteoarthritis cohort. Osteoarthr Cartil 23(4):544–549CrossRefPubMedGoogle Scholar
  37. 37.
    Bastick AN, Belo JN, Runhaar J, Bierma-Zeinstra SM (2015) What are the prognostic factors for radiographic progression of knee osteoarthritis? A meta-analysis. Clin Orthop Relat Res 473(9):2969–2989CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Cooper C, Snow S, McAlindon TE, Kellingray S, Stuart B, Coggon D et al (2000) Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum 43(5):995CrossRefPubMedGoogle Scholar
  39. 39.
    Zhang Y, Niu J, Felson DT, Choi HK, Nevitt M, Neogi T (2010) Methodologic challenges in studying risk factors for progression of knee osteoarthritis. Arthritis Care Res 62(11):1527–1532CrossRefGoogle Scholar
  40. 40.
    Monroe SM, Slavich GM, Gotlib IH (2014) Life stress and family history for depression: the moderating role of past depressive episodes. J Psychiatr Res 49:90–95CrossRefPubMedGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2016

Authors and Affiliations

  • Alan M. Rathbun
    • 1
  • Michelle S. Yau
    • 2
  • Michelle Shardell
    • 3
  • Elizabeth A. Stuart
    • 4
  • Marc C. Hochberg
    • 5
  1. 1.Department of Epidemiology and Public HealthUniversity of Maryland School of MedicineBaltimoreUSA
  2. 2.Harvard Medical SchoolHebrew SeniorLife Institute for Aging ResearchBostonUSA
  3. 3.Translational Gerontology BranchNational Institutes on AgingBethesdaUSA
  4. 4.Johns Hopkins University Bloomberg School of Public HealthBaltimoreUSA
  5. 5.Division of Rheumatology and Clinical Immunology, Department of MedicineUniversity of Maryland School of MedicineBaltimoreUSA

Personalised recommendations